Integrated Biospecimen & Imaging Collection Network

Research Management Partners (RMP) delivers fully integrated biospecimen and imaging collection capabilities through an embedded clinical research network operating within active healthcare practices across Florida and Puerto Rico, with scalable expansion across the United States.

Our infrastructure includes a network of 10 affiliated laboratories across Florida, operating under CLIA-certified standards, alongside access to dedicated imaging practices, enabling seamless execution of both biospecimen collection and imaging-based study requirements.

Unlike fragmented collection networks or third-party brokers, RMP provides direct operational control at the point of care, ensuring protocol adherence, data integrity, and real-time coordination across sites, laboratories, and sponsors.

Scalable, High-Quality Execution Within a Real Clinical Network

RMP supports biomarker-driven, translational, and clinical research programs with direct access to diverse, pre-qualified patient populations (>1.2M patients across our MSO network).

Typical operational performance includes:

• Study start-up timelines: 2–4 weeks from activation to first patient

• High protocol adherence and sample integrity under standardized SOPs

• Real-time operational oversight across all participating sites

• Consistent cross-site execution through centralized governance

Comprehensive Biospecimen Capabilities

RMP supports the full lifecycle of biospecimen collection programs:

• EMR-driven patient identification and recruitment

• IRB-compliant informed consent and enrollment

• Biospecimen collection by medically trained clinical staff

• On-site processing per protocol specifications

• IATA-compliant packaging and shipment

• Real-time tracking and chain-of-custody management

Our integrated model minimizes variability, protects sample integrity, and ensures consistent execution across all sites.

Types of Biospecimens Supported

We support a broad range of protocol-driven collections:

• Whole blood

• Serum and plasma

• Peripheral Blood Mononuclear Cells (PBMC)

• DNA and RNA samples

• Tissue samples (protocol-dependent)

• Stool and urine

All collections are executed under study-specific protocols, SOPs, and applicable regulatory frameworks.

Integrated Laboratory Infrastructure (CLIA-Certified Network)

Through our network of 10 affiliated laboratories, RMP provides:

• CLIA-certified processing and analysis capabilities

• Standardized workflows (PBMC, plasma, serum, tissue)

• Temperature-controlled storage (-80°C and LN2)

• Protocol-specific handling and logistics coordination

• IATA-compliant packaging and shipment

• Real-time chain-of-custody tracking

This eliminates delays associated with third-party coordination and ensures end-to-end control of biospecimen workflows.

Integrated Imaging Capabilities

RMP enhances biospecimen programs through access to dedicated imaging practices, enabling:

• Baseline and longitudinal imaging

• Disease monitoring and response assessment

• Imaging-linked biomarker studies

• Protocol-driven imaging endpoints

This is particularly valuable for oncology, neurology, and complex chronic disease studies, where imaging plays a critical role in endpoint evaluation.

Operational Infrastructure & Readiness

RMP provides a high-performance execution environment:

• Multi-site deployment across 10–25+ active research sites

• Rapid activation through pre-qualified clinical locations

• Centralized regulatory, operational, and quality oversight

• GCP-aligned SOPs across all sites

• Medically trained staff embedded in clinical workflows

Use Cases & Program Types

RMP supports a wide range of biospecimen-driven programs:

• Biomarker discovery and validation

• Longitudinal sample collection studies

• Oncology and specialty disease screening

• Gastroenterology and metabolic disease programs

• Infectious disease and vaccine-related studies

• Real-world evidence (RWE) and observational research

The RMP Advantage

RMP operates directly within active clinical care environments, enabling:

• Immediate access to real-world patient populations

• Accelerated recruitment through embedded workflows

• High protocol adherence through continuity of care

• Standardized, high-quality collection across all sites

• Real-time visibility and centralized oversight

We are not a passive collection network—we are a centralized execution partner.

Pilot Program Approach

To accelerate onboarding and reduce operational risk, RMP offers pilot programs across 2–3 sites to validate:

• Recruitment performance

• Operational efficiency

• Sample quality and protocol adherence

Pilot programs can be deployed within 2–4 weeks and scaled rapidly across the network.

Launch Your Program with RMP

If you are planning or expanding a biospecimen or imaging-based study, RMP provides rapid deployment, scalable infrastructure, and reliable site-level execution.

                     

 

 

                     Request a Pilot Program, Feasibility Assessment, or Capability Review

                                              Email: admin@rmpsmo.com
                                                  Phone: 786-464-0868
                                               Response within 24 hours